Efficacy and Safety of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan
Clinical trial NCT01263483 · COMPLETED
Trial details
- NCT number
- NCT01263483
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2008-04-01
- Enrollment
- 230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.